Insights

Global Expansion Revance operates a diversified portfolio in aesthetics, skincare and therapeutics with a presence in 60 countries, creating opportunities to expand distribution and cross sell across geographies and channels.

Financial Backing Revance reports revenue in the 250 to 500 million range and has additional funding, indicating capacity to invest in co development and strategic partnerships to accelerate product launches and market expansion.

Marketing Partnerships Recent high profile consumer campaigns such as the Blue Lizard sunscreen takeover demonstrate openness to co branding and large scale promotional partnerships with consumer brands.

Digital Readiness A modern technology stack including Google Cloud, Microsoft Teams and modern front end frameworks signals readiness for data driven partnerships, digital marketing analytics, and scalable product launches.

Leadership Access Direct access to senior marketing leadership, including Steve Gallopo and Nicole Watson, can accelerate alignment on co marketing and product collaboration opportunities.

Revance Tech Stack

Revance uses 8 technology products and services including SAS Office Analytics, Autodesk Revit, CookieYes, and more. Explore Revance's tech stack below.

  • SAS Office Analytics
    Business Intelligence
  • Autodesk Revit
    Cad & Graphics
  • CookieYes
    Cookie Compliance
  • IQVIA
    Health Platform
  • Google Cloud Platform
    Infrastructure As A Service
  • Piwik
    System Analytics & Monitoring
  • JUnit
    Testing And Qa
  • Coupa
    Travel And Expense Management

Media & News

Revance's Email Address Formats

Revance uses at least 1 format(s):
Revance Email FormatsExamplePercentage
First.Last@revance.comJohn.Doe@revance.com
56%
FLast@revance.comJDoe@revance.com
38%
FirstLast@revance.comJohnDoe@revance.com
4%
Last@revance.comDoe@revance.com
2%

Frequently Asked Questions

What is Revance's phone number?

Minus sign iconPlus sign icon
You can contact Revance's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Revance's stock symbol?

Minus sign iconPlus sign icon
Revance is a publicly traded company; the company's stock symbol is RVNC.

What is Revance's official website and social media links?

Minus sign iconPlus sign icon
Revance's official website is revance.com and has social profiles on LinkedInCrunchbase.

What is Revance's SIC code NAICS code?

Minus sign iconPlus sign icon
Revance's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Revance have currently?

Minus sign iconPlus sign icon
As of July 2026, Revance has approximately 764 employees across 4 continents, including North AmericaEuropeAfrica. Key team members include Cfo & Executive Vice President Corporate Development: L. S.Chief Technology Officer: S. K.Chief Scientific Officer: C. G.. Explore Revance's employee directory with LeadIQ.

What industry does Revance belong to?

Minus sign iconPlus sign icon
Revance operates in the Biotechnology Research industry.

What technology does Revance use?

Minus sign iconPlus sign icon
Revance's tech stack includes SAS Office AnalyticsAutodesk RevitCookieYesIQVIAGoogle Cloud PlatformPiwikJUnitCoupa.

What is Revance's email format?

Minus sign iconPlus sign icon
Revance's email format typically follows the pattern of First.Last@revance.com. Find more Revance email formats with LeadIQ.

How much funding has Revance raised to date?

Minus sign iconPlus sign icon
As of July 2026, Revance has raised $1.7B in funding. The last funding round occurred on Mar 04, 2024 for $100M.
Revance logo

Revance

Biotechnology ResearchTennessee, United States501-1000 Employees

Revance is a privately held, fully integrated global biotechnology company based in Nashville, Tennessee, focused on aesthetics, skincare, and therapeutics. It operates in the biotechnology research industry and employs between 501 and 1000 people. The company pursues science-powered innovation and develops differentiated products for health, beauty, and wellness across generations. Revance markets its products in about 60 countries and maintains a diversified portfolio across global markets. Financial data in the provided information indicate revenue in the $250 million to $500 million range and funding of $100 million.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
RVNC
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
501-1000

Section iconFunding & Financials

  • $1.7B

    Revance has raised a total of $1.7B of funding over 17 rounds. Their latest funding round was raised on Mar 04, 2024 in the amount of $100Mas a post_ipo_equity.

  • $250M$500M

    Revance's revenue is estimated to be in the range of $250M$500M

Section iconFunding & Financials

  • $1.7B

    Revance has raised a total of $1.7B of funding over 17 rounds. Their latest funding round was raised on Mar 04, 2024 in the amount of $100Mas a post_ipo_equity.

  • $250M$500M

    Revance's revenue is estimated to be in the range of $250M$500M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.